0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Verapamil Hydrochloride Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1Z13841
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Verapamil Hydrochloride Injection Market Research Report 2023
BUY CHAPTERS

Global Verapamil Hydrochloride Injection Market Research Report 2025

Code: QYRE-Auto-1Z13841
Report
May 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Verapamil Hydrochloride Injection Market

The global market for Verapamil Hydrochloride Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Verapamil Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Verapamil Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Verapamil Hydrochloride Injection include Pfizer, Exela Pharma, Mankind Pharma, ACIC Pharmaceuticals, Zydus Pharmaceuticals, Gland Pharma, China Res Double-Crane, Shiyao YINHU Pharmaceutical, Jilin Jinsheng Pharmaceutical, Shanghai Harvest Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Verapamil Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Verapamil Hydrochloride Injection.
The Verapamil Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Verapamil Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Verapamil Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Verapamil Hydrochloride Injection Market Report

Report Metric Details
Report Name Verapamil Hydrochloride Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Exela Pharma, Mankind Pharma, ACIC Pharmaceuticals, Zydus Pharmaceuticals, Gland Pharma, China Res Double-Crane, Shiyao YINHU Pharmaceutical, Jilin Jinsheng Pharmaceutical, Shanghai Harvest Pharmaceutical, Jiangsu Langou Drug, Jiangsu Ruinian Qianjin Pharmacy, Chongqing Yaoyou Pharmacy, Hubei Weishi, Duoduo Pharmaceutical, Harbin Pharm. Group Sanjing Pharmaceutical, Chia Tai-Tianqing Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Verapamil Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Verapamil Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Verapamil Hydrochloride Injection Market report?

Ans: The main players in the Verapamil Hydrochloride Injection Market are Pfizer, Exela Pharma, Mankind Pharma, ACIC Pharmaceuticals, Zydus Pharmaceuticals, Gland Pharma, China Res Double-Crane, Shiyao YINHU Pharmaceutical, Jilin Jinsheng Pharmaceutical, Shanghai Harvest Pharmaceutical, Jiangsu Langou Drug, Jiangsu Ruinian Qianjin Pharmacy, Chongqing Yaoyou Pharmacy, Hubei Weishi, Duoduo Pharmaceutical, Harbin Pharm. Group Sanjing Pharmaceutical, Chia Tai-Tianqing Pharmaceutical

What are the Application segmentation covered in the Verapamil Hydrochloride Injection Market report?

Ans: The Applications covered in the Verapamil Hydrochloride Injection Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Verapamil Hydrochloride Injection Market report?

Ans: The Types covered in the Verapamil Hydrochloride Injection Market report are Oral, Intravenous Injection

Recommended Reports

Hydrochloride Injections

Cardiovascular Drugs

Injection Medicines

1 Verapamil Hydrochloride Injection Market Overview
1.1 Product Definition
1.2 Verapamil Hydrochloride Injection by Type
1.2.1 Global Verapamil Hydrochloride Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Intravenous Injection
1.3 Verapamil Hydrochloride Injection by Application
1.3.1 Global Verapamil Hydrochloride Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Verapamil Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Verapamil Hydrochloride Injection Revenue 2020-2031
1.4.2 Global Verapamil Hydrochloride Injection Sales 2020-2031
1.4.3 Global Verapamil Hydrochloride Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Verapamil Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Verapamil Hydrochloride Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Verapamil Hydrochloride Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Verapamil Hydrochloride Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Verapamil Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Verapamil Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Verapamil Hydrochloride Injection, Product Type & Application
2.7 Global Key Manufacturers of Verapamil Hydrochloride Injection, Date of Enter into This Industry
2.8 Global Verapamil Hydrochloride Injection Market Competitive Situation and Trends
2.8.1 Global Verapamil Hydrochloride Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Verapamil Hydrochloride Injection Players Market Share by Revenue
2.8.3 Global Verapamil Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Verapamil Hydrochloride Injection Market Scenario by Region
3.1 Global Verapamil Hydrochloride Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Verapamil Hydrochloride Injection Sales by Region: 2020-2031
3.2.1 Global Verapamil Hydrochloride Injection Sales by Region: 2020-2025
3.2.2 Global Verapamil Hydrochloride Injection Sales by Region: 2026-2031
3.3 Global Verapamil Hydrochloride Injection Revenue by Region: 2020-2031
3.3.1 Global Verapamil Hydrochloride Injection Revenue by Region: 2020-2025
3.3.2 Global Verapamil Hydrochloride Injection Revenue by Region: 2026-2031
3.4 North America Verapamil Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Verapamil Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Verapamil Hydrochloride Injection Sales by Country (2020-2031)
3.4.3 North America Verapamil Hydrochloride Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Verapamil Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Verapamil Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Verapamil Hydrochloride Injection Sales by Country (2020-2031)
3.5.3 Europe Verapamil Hydrochloride Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Verapamil Hydrochloride Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Verapamil Hydrochloride Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Verapamil Hydrochloride Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Verapamil Hydrochloride Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Verapamil Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Verapamil Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Verapamil Hydrochloride Injection Sales by Country (2020-2031)
3.7.3 Latin America Verapamil Hydrochloride Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Verapamil Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Verapamil Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Verapamil Hydrochloride Injection Sales by Type (2020-2031)
4.1.1 Global Verapamil Hydrochloride Injection Sales by Type (2020-2025)
4.1.2 Global Verapamil Hydrochloride Injection Sales by Type (2026-2031)
4.1.3 Global Verapamil Hydrochloride Injection Sales Market Share by Type (2020-2031)
4.2 Global Verapamil Hydrochloride Injection Revenue by Type (2020-2031)
4.2.1 Global Verapamil Hydrochloride Injection Revenue by Type (2020-2025)
4.2.2 Global Verapamil Hydrochloride Injection Revenue by Type (2026-2031)
4.2.3 Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2020-2031)
4.3 Global Verapamil Hydrochloride Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Verapamil Hydrochloride Injection Sales by Application (2020-2031)
5.1.1 Global Verapamil Hydrochloride Injection Sales by Application (2020-2025)
5.1.2 Global Verapamil Hydrochloride Injection Sales by Application (2026-2031)
5.1.3 Global Verapamil Hydrochloride Injection Sales Market Share by Application (2020-2031)
5.2 Global Verapamil Hydrochloride Injection Revenue by Application (2020-2031)
5.2.1 Global Verapamil Hydrochloride Injection Revenue by Application (2020-2025)
5.2.2 Global Verapamil Hydrochloride Injection Revenue by Application (2026-2031)
5.2.3 Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2020-2031)
5.3 Global Verapamil Hydrochloride Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Verapamil Hydrochloride Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Exela Pharma
6.2.1 Exela Pharma Company Information
6.2.2 Exela Pharma Description and Business Overview
6.2.3 Exela Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Exela Pharma Verapamil Hydrochloride Injection Product Portfolio
6.2.5 Exela Pharma Recent Developments/Updates
6.3 Mankind Pharma
6.3.1 Mankind Pharma Company Information
6.3.2 Mankind Pharma Description and Business Overview
6.3.3 Mankind Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mankind Pharma Verapamil Hydrochloride Injection Product Portfolio
6.3.5 Mankind Pharma Recent Developments/Updates
6.4 ACIC Pharmaceuticals
6.4.1 ACIC Pharmaceuticals Company Information
6.4.2 ACIC Pharmaceuticals Description and Business Overview
6.4.3 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
6.4.5 ACIC Pharmaceuticals Recent Developments/Updates
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Company Information
6.5.2 Zydus Pharmaceuticals Description and Business Overview
6.5.3 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.6 Gland Pharma
6.6.1 Gland Pharma Company Information
6.6.2 Gland Pharma Description and Business Overview
6.6.3 Gland Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gland Pharma Verapamil Hydrochloride Injection Product Portfolio
6.6.5 Gland Pharma Recent Developments/Updates
6.7 China Res Double-Crane
6.7.1 China Res Double-Crane Company Information
6.7.2 China Res Double-Crane Description and Business Overview
6.7.3 China Res Double-Crane Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China Res Double-Crane Verapamil Hydrochloride Injection Product Portfolio
6.7.5 China Res Double-Crane Recent Developments/Updates
6.8 Shiyao YINHU Pharmaceutical
6.8.1 Shiyao YINHU Pharmaceutical Company Information
6.8.2 Shiyao YINHU Pharmaceutical Description and Business Overview
6.8.3 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.8.5 Shiyao YINHU Pharmaceutical Recent Developments/Updates
6.9 Jilin Jinsheng Pharmaceutical
6.9.1 Jilin Jinsheng Pharmaceutical Company Information
6.9.2 Jilin Jinsheng Pharmaceutical Description and Business Overview
6.9.3 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.9.5 Jilin Jinsheng Pharmaceutical Recent Developments/Updates
6.10 Shanghai Harvest Pharmaceutical
6.10.1 Shanghai Harvest Pharmaceutical Company Information
6.10.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.10.3 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.10.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
6.11 Jiangsu Langou Drug
6.11.1 Jiangsu Langou Drug Company Information
6.11.2 Jiangsu Langou Drug Description and Business Overview
6.11.3 Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Langou Drug Verapamil Hydrochloride Injection Product Portfolio
6.11.5 Jiangsu Langou Drug Recent Developments/Updates
6.12 Jiangsu Ruinian Qianjin Pharmacy
6.12.1 Jiangsu Ruinian Qianjin Pharmacy Company Information
6.12.2 Jiangsu Ruinian Qianjin Pharmacy Description and Business Overview
6.12.3 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product Portfolio
6.12.5 Jiangsu Ruinian Qianjin Pharmacy Recent Developments/Updates
6.13 Chongqing Yaoyou Pharmacy
6.13.1 Chongqing Yaoyou Pharmacy Company Information
6.13.2 Chongqing Yaoyou Pharmacy Description and Business Overview
6.13.3 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product Portfolio
6.13.5 Chongqing Yaoyou Pharmacy Recent Developments/Updates
6.14 Hubei Weishi
6.14.1 Hubei Weishi Company Information
6.14.2 Hubei Weishi Description and Business Overview
6.14.3 Hubei Weishi Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hubei Weishi Verapamil Hydrochloride Injection Product Portfolio
6.14.5 Hubei Weishi Recent Developments/Updates
6.15 Duoduo Pharmaceutical
6.15.1 Duoduo Pharmaceutical Company Information
6.15.2 Duoduo Pharmaceutical Description and Business Overview
6.15.3 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.15.5 Duoduo Pharmaceutical Recent Developments/Updates
6.16 Harbin Pharm. Group Sanjing Pharmaceutical
6.16.1 Harbin Pharm. Group Sanjing Pharmaceutical Company Information
6.16.2 Harbin Pharm. Group Sanjing Pharmaceutical Description and Business Overview
6.16.3 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.16.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments/Updates
6.17 Chia Tai-Tianqing Pharmaceutical
6.17.1 Chia Tai-Tianqing Pharmaceutical Company Information
6.17.2 Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.17.3 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
6.17.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Verapamil Hydrochloride Injection Industry Chain Analysis
7.2 Verapamil Hydrochloride Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Verapamil Hydrochloride Injection Production Mode & Process Analysis
7.4 Verapamil Hydrochloride Injection Sales and Marketing
7.4.1 Verapamil Hydrochloride Injection Sales Channels
7.4.2 Verapamil Hydrochloride Injection Distributors
7.5 Verapamil Hydrochloride Injection Customer Analysis
8 Verapamil Hydrochloride Injection Market Dynamics
8.1 Verapamil Hydrochloride Injection Industry Trends
8.2 Verapamil Hydrochloride Injection Market Drivers
8.3 Verapamil Hydrochloride Injection Market Challenges
8.4 Verapamil Hydrochloride Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Verapamil Hydrochloride Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Verapamil Hydrochloride Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Verapamil Hydrochloride Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Verapamil Hydrochloride Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Verapamil Hydrochloride Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Verapamil Hydrochloride Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Verapamil Hydrochloride Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Verapamil Hydrochloride Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Verapamil Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Verapamil Hydrochloride Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Verapamil Hydrochloride Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Verapamil Hydrochloride Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Verapamil Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Verapamil Hydrochloride Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Verapamil Hydrochloride Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Verapamil Hydrochloride Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Verapamil Hydrochloride Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Verapamil Hydrochloride Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Verapamil Hydrochloride Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Verapamil Hydrochloride Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Verapamil Hydrochloride Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Verapamil Hydrochloride Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Verapamil Hydrochloride Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Verapamil Hydrochloride Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Verapamil Hydrochloride Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Verapamil Hydrochloride Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Verapamil Hydrochloride Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Verapamil Hydrochloride Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Verapamil Hydrochloride Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Verapamil Hydrochloride Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Verapamil Hydrochloride Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Verapamil Hydrochloride Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Verapamil Hydrochloride Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Verapamil Hydrochloride Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Verapamil Hydrochloride Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Verapamil Hydrochloride Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Verapamil Hydrochloride Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Verapamil Hydrochloride Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Verapamil Hydrochloride Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Verapamil Hydrochloride Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Verapamil Hydrochloride Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Verapamil Hydrochloride Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Verapamil Hydrochloride Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Verapamil Hydrochloride Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Verapamil Hydrochloride Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Verapamil Hydrochloride Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Verapamil Hydrochloride Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Verapamil Hydrochloride Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Verapamil Hydrochloride Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Verapamil Hydrochloride Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Exela Pharma Company Information
 Table 76. Exela Pharma Description and Business Overview
 Table 77. Exela Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Exela Pharma Verapamil Hydrochloride Injection Product
 Table 79. Exela Pharma Recent Developments/Updates
 Table 80. Mankind Pharma Company Information
 Table 81. Mankind Pharma Description and Business Overview
 Table 82. Mankind Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mankind Pharma Verapamil Hydrochloride Injection Product
 Table 84. Mankind Pharma Recent Developments/Updates
 Table 85. ACIC Pharmaceuticals Company Information
 Table 86. ACIC Pharmaceuticals Description and Business Overview
 Table 87. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product
 Table 89. ACIC Pharmaceuticals Recent Developments/Updates
 Table 90. Zydus Pharmaceuticals Company Information
 Table 91. Zydus Pharmaceuticals Description and Business Overview
 Table 92. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product
 Table 94. Zydus Pharmaceuticals Recent Developments/Updates
 Table 95. Gland Pharma Company Information
 Table 96. Gland Pharma Description and Business Overview
 Table 97. Gland Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Gland Pharma Verapamil Hydrochloride Injection Product
 Table 99. Gland Pharma Recent Developments/Updates
 Table 100. China Res Double-Crane Company Information
 Table 101. China Res Double-Crane Description and Business Overview
 Table 102. China Res Double-Crane Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. China Res Double-Crane Verapamil Hydrochloride Injection Product
 Table 104. China Res Double-Crane Recent Developments/Updates
 Table 105. Shiyao YINHU Pharmaceutical Company Information
 Table 106. Shiyao YINHU Pharmaceutical Description and Business Overview
 Table 107. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 109. Shiyao YINHU Pharmaceutical Recent Developments/Updates
 Table 110. Jilin Jinsheng Pharmaceutical Company Information
 Table 111. Jilin Jinsheng Pharmaceutical Description and Business Overview
 Table 112. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 114. Jilin Jinsheng Pharmaceutical Recent Developments/Updates
 Table 115. Shanghai Harvest Pharmaceutical Company Information
 Table 116. Shanghai Harvest Pharmaceutical Description and Business Overview
 Table 117. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 119. Shanghai Harvest Pharmaceutical Recent Developments/Updates
 Table 120. Jiangsu Langou Drug Company Information
 Table 121. Jiangsu Langou Drug Description and Business Overview
 Table 122. Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jiangsu Langou Drug Verapamil Hydrochloride Injection Product
 Table 124. Jiangsu Langou Drug Recent Developments/Updates
 Table 125. Jiangsu Ruinian Qianjin Pharmacy Company Information
 Table 126. Jiangsu Ruinian Qianjin Pharmacy Description and Business Overview
 Table 127. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product
 Table 129. Jiangsu Ruinian Qianjin Pharmacy Recent Developments/Updates
 Table 130. Chongqing Yaoyou Pharmacy Company Information
 Table 131. Chongqing Yaoyou Pharmacy Description and Business Overview
 Table 132. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product
 Table 134. Chongqing Yaoyou Pharmacy Recent Developments/Updates
 Table 135. Hubei Weishi Company Information
 Table 136. Hubei Weishi Description and Business Overview
 Table 137. Hubei Weishi Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hubei Weishi Verapamil Hydrochloride Injection Product
 Table 139. Hubei Weishi Recent Developments/Updates
 Table 140. Duoduo Pharmaceutical Company Information
 Table 141. Duoduo Pharmaceutical Description and Business Overview
 Table 142. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 144. Duoduo Pharmaceutical Recent Developments/Updates
 Table 145. Harbin Pharm. Group Sanjing Pharmaceutical Company Information
 Table 146. Harbin Pharm. Group Sanjing Pharmaceutical Description and Business Overview
 Table 147. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 149. Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments/Updates
 Table 150. Chia Tai-Tianqing Pharmaceutical Company Information
 Table 151. Chia Tai-Tianqing Pharmaceutical Description and Business Overview
 Table 152. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product
 Table 154. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Verapamil Hydrochloride Injection Distributors List
 Table 158. Verapamil Hydrochloride Injection Customers List
 Table 159. Verapamil Hydrochloride Injection Market Trends
 Table 160. Verapamil Hydrochloride Injection Market Drivers
 Table 161. Verapamil Hydrochloride Injection Market Challenges
 Table 162. Verapamil Hydrochloride Injection Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Verapamil Hydrochloride Injection
 Figure 2. Global Verapamil Hydrochloride Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Verapamil Hydrochloride Injection Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Intravenous Injection Product Picture
 Figure 6. Global Verapamil Hydrochloride Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Verapamil Hydrochloride Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Global Verapamil Hydrochloride Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Verapamil Hydrochloride Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Verapamil Hydrochloride Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Verapamil Hydrochloride Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Verapamil Hydrochloride Injection Report Years Considered
 Figure 16. Verapamil Hydrochloride Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Verapamil Hydrochloride Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Verapamil Hydrochloride Injection Players: Market Share by Revenue in Verapamil Hydrochloride Injection in 2024
 Figure 19. Verapamil Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Verapamil Hydrochloride Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Verapamil Hydrochloride Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Verapamil Hydrochloride Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Verapamil Hydrochloride Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Verapamil Hydrochloride Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Verapamil Hydrochloride Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Verapamil Hydrochloride Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Verapamil Hydrochloride Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Verapamil Hydrochloride Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Verapamil Hydrochloride Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Verapamil Hydrochloride Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Verapamil Hydrochloride Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Verapamil Hydrochloride Injection by Type (2020-2031)
 Figure 53. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Verapamil Hydrochloride Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Verapamil Hydrochloride Injection by Application (2020-2031)
 Figure 56. Global Verapamil Hydrochloride Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Verapamil Hydrochloride Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS